MLF2
Myeloid leukemia factor 2
Also known as: MLF2_HUMAN, NTN4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15773
- Gene
- MLF2
- Ensembl
- ENSG00000089693
- Chromosome
- 12
- Canonical length
- 248 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
Predicted to be involved in regulation of DNA-templated transcription. Located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
248 residues, UniProt reviewed canonical sequence.
>Q15773|MLF2
1 MFRFMRDVEP EDPMFLMDPF AIHRQHMSRM LSGGFGYSPF LSITDGNMPG TRPASRRMQQ
61 AGAVSPFGML GMSGGFMDMF GMMNDMIGNM EHMTAGGNCQ TFSSSTVISY SNTGDGAPKV
121 YQETSEMRSA PGGIRETRRT VRDSDSGLEQ MSIGHHIRDR AHILQRSRNH RTGDQEERQD
181 YINLDESEAA AFDDEWRRET SRFRQQRPLE FRRLESSGAG GRRAEGPPRL AIQGPEDSPS
241 RQSRRYDWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MLF2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 291 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 291 nTPM
- liver: 283 nTPM
- basal ganglia: 279 nTPM
- choroid plexus: 252 nTPM
- hippocampal formation: 243 nTPM
- amygdala: 240 nTPM
Single-cell type
- syncytiotrophoblasts: 489 nCPM
- esophageal apical cells: 378 nCPM
- esophageal suprabasal cells: 322 nCPM
- cytotrophoblasts: 313 nCPM
- migrating cytotrophoblasts: 309 nCPM
- esophageal basal cells: 302 nCPM
Immune cell
- neutrophil: 530 nTPM
- eosinophil: 462 nTPM
- basophil: 260 nTPM
- plasmacytoid DC: 232 nTPM
- myeloid DC: 134 nTPM
- non-classical monocyte: 130 nTPM
Brain region
- cerebral cortex: 230 nTPM
- hippocampal formation: 203 nTPM
- basal ganglia: 197 nTPM
- white matter: 190 nTPM
- hypothalamus: 189 nTPM
- choroid plexus: 180 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.86
- gnomAD missense Z
- 1.61
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MLF2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MLF2 as an antibody target. Whether an autoantibody or antibody against MLF2 could matter depends on whether native MLF2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MLF2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MLF2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...